-
API supply chain needs to address future challenges arising from China situation: CPhI Worldwide panel
CPhIonline
October 27, 2021
The COVID-19 pandemic has exposed weaknesses in the complex supply chain for active pharmaceutical ingredients (APIs) and the sector needs to address the challenges of rising production costs in China...
-
Remarkable Agility
cphi-online
August 24, 2021
A quarterly series blog posts about responsible supply chain management from the PSCI Chair, Manjit Singh
-
Biden Administration to support resilience of US pharma supply chain
europeanpharmaceuticalreview
August 03, 2021
US President announces $60 million in funding to support domestic API production and a consortium to onshore essential medicine manufacturing.
-
RBI bulletin calls for diversification of pharma raw material imports, increasing pharma R&D spends
expresspharma
July 16, 2021
Apart from securing own supply chain, the country can also use the pandemic to elevate the sector's position in the global supply chain by standing as a reliable exporter of pharmaceuticals, it said.
-
FDA Provides New Guidance to Further Enhance the Security of Prescription Drugs in U.S. Supply Chain
americanpharmaceuticalreview
June 07, 2021
The FDA is finalizing two guidance documents and making available two draft guidance documents to help ensure that prescription drugs are identified and traced properly as they move through the supply chain.
-
COVID-19 Survey: Professionals Optimistic Amid Continued Global Supply Chain Disruptions
prnewswire
June 07, 2021
As a follow up to survey results released on March 11, 2020, April 14, 2020 and July 20, 2020, today Institute for Supply Management® (ISM®) released its fourth round of dedicated research on COVID-19 impacts on businesses and their supply chains.
-
Moderna enters drug substance production deal with Lonza
pharmaceutical-technology
June 04, 2021
Moderna has signed a new agreement with Lonza to create a new production line at the latter’s Geleen facility in the Netherlands, which will support drug substance production for its international supply chain.
-
ASPA, Messe Frankfurt India to organise a panel discussion securing pharma supply chain
expresspharma
June 04, 2021
Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19.
-
Alliance to Zero Founded for ‘Green’ Pharma Supply Chain Initiative
contractpharma
June 04, 2021
Goal is to help pharma sector comply with net-zero emissions in line with the Paris Climate Agreement.
-
First UK-based clinical trial focused viral vector manufacturer announces launch
pharmatimes
April 30, 2021
ViroCell Biologics, the first clinical trial focused viral vector manufacturer in the UK, has announced its official launch, with the aim of becoming the ‘supplier of choice’ for viral vectors and gene modified cells.